Table 2.
Assessment of investigated biomarkers and Pb.
| Parameters | Group A | Group B | P value |
|---|---|---|---|
| Number | 26 | 26 | — |
| Pb (µg/dL), mean ± SD | 14.43 ± 1.01 | 5.01 ± 1.41 | <.001 |
| MDA (nmol/mL), mean ± SD | 6.40 ± 0.27 | 1.62 ± 0.21 | <.001 |
| Visfatin (ng/mL), mean ± SD | 23.19 ± 0.96 | 3.88 ± 0.58 | <.001 |
| Insulin (mU/L), mean ± SD | 22.14 ± 1.31 | 11.26 ± 0.75 | <.001 |
| FBS (mg/dL), mean ± SD | 118.4 ± 26.1 | 82.7 ± 9.2 | <.001 |
| IL-1β (pg/mL), mean ± SD | 330.25 ± 10.34 | 12.35 ± 1.43 | <.001 |
| Vitamin D (ng/mL), mean ± SD | 11.99 ± 1.55 | 35.41 ± 3.16 | <.001 |
FBS = fasting blood sugar, IL-1 = interleukin-1, MDA = malonaldehyde, Pb = lead, SD = standard deviation.